Drug Delivery: Advances in drug delivery vehicles and devices - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
Drug Delivery
Tablets & capsules, liquid-dosage forms. Inhalables & intranasals. Injectables: intravenous, intramuscular & subcutaneous. Nanotechnology, dissolvable films and tablets & radio frequency transdermal drug delivery.
Receive Content Alerts For:
Drug Delivery
« Previous
1234567891011121314151617181920212223
Next »

Everybody's Got Problems

June 2, 2010
By: Control, a senior compliance officer
Pharmaceutical Technology

Too much or too little control can actually lead to the same result.

GSK Believes in the Power of Printing APIs

May 28, 2010
By: Stephanie Sutton
Pharmaceutical Technology Europe

A collaboration involving GlaxoSmithKline and two British universities is looking to create faster acting medicines with a technology that prints APIs onto a tablet?s surface.

Week of May 24, 2010: Company and People Notes: Bayer to Open San Francisco Innovation Hub; Lonza Bioscience Names COO; And More.

May 27, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Bayer to Open San Francisco Innovation Hub; Lonza Bioscience Names COO; And More.

Week of May 17, 2010: Company and People Notes: Lonza Acquires MODA; Sigma-Aldrich Exec to Retire; And More.

May 20, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Lonza Acquires MODA; Sigma-Aldrich Exec to Retire; And More.

Week Of May 10, 2010: Company And People Notes: Ariad and Merck Restructure Collaboration; Genzyme Changes Leadership; and More

May 13, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Week Of May 10, 2010: Company And People Notes: Ariad and Merck Restructure Collaboration; Genzyme Changes Leadership; and More

Week Of May 3, 2010: Company And People Notes: FDA Approves AstraZeneca's and Pozen's Vimovo; Merck Announces Management Changes; And More.

May 6, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

FDA Approves AstraZeneca's and Pozen's Vimovo; Merck Announces Management Changes; And More.

Enterprise-Level Change Control

May 2, 2010
By: Marina Aslanyan
Pharmaceutical Technology

A Pharma Business Imperative.

A Very Brady FDA

May 2, 2010
By: Michelle Hoffman
Pharmaceutical Technology

FDA wants industry to talk to them about the science underlying process innovations—really.

Report from Brazil

May 2, 2010
By: Hellen Berger
Pharmaceutical Technology

The growth of Brazil's generic-drug market is on a fast track, but what are the projections for the sector's future?

« Previous
1234567891011121314151617181920212223
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
25%
To select processes for both new and legacy products
20%
Do not use QbD
23%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here